Improving Iron Status Through Consumption Of Iron Fortified Cowpea: An Intervention Study

Sponsor
Wageningen University (Other)
Overall Status
Completed
CT.gov ID
NCT01208363
Collaborator
Noguchi Memorial Institute for Medical Research (Other), Nestlé Foundation (Other)
240
1
2
10
24.1

Study Details

Study Description

Brief Summary

Rationale: Iron deficiency and zinc deficiency, are of public health significance in sub-Saharan Africa. An estimated 50% of children (5-14 years) in developing countries suffer from anaemia, half of which is estimated iron deficiency anaemia. Interventions have been designed and implemented over the years towards solving hunger and anaemia especially among school age children. One of such interventions is School Feeding Programme (SFP) which is common in both developing and industrialized countries. SFP has been part of the Ghanaian educational system for well over 40 years, albeit on small scale. The main stay of the programme that makes it distinguishable from other past and existing school feeding programmes is its reliance on locally produced and available foods, such as cowpeas. Legume staples like cowpea have been identified to be important sources of protein and non-heme iron to rural populations of developing countries like Ghana. The problem however is the low bioavailability of these micronutrients from these legumes.

Objective: To assess the efficacy of iron fortified cowpea based meal (Tubani) in improving iron status of primary school children in rural northern Ghana Study design: A randomized double blind parallel design will be conducted. One group will receive iron fortified Tubani with NaFeEDTA and the other group will receive unfortified Tubani.

Study population: Two hundred and forty apparently healthy pupils in lower primary school will participate. The participating schools have a school feeding programme currently in operation.

Intervention (if applicable): Children will be fed Tubani containing 10mg of fortification iron (in the form of NaFeEDTA) three times in a week for six months. Weight, height and blood samples will be measured at baseline and after six months of intervention. Participants will be treated against intestinal parasites before start of intervention and halfway through the intervention.

Main study parameters/endpoints: The main study endpoint is iron-deficiency anaemia (IDA). IDA will be defined as concurrent anaemia and iron deficiency. Whole blood will be collected for the analysis of Hb, serum ferritin (SF), serum transferring receptor (sTfR) and C-reactive protein (CRP). Anemia will be defined as a hemoglobin concentration <115 g/L, and iron deficiency will be defined as an SF concentration <12 µg/L.

Venipunctures occasionally lead to bruises or small local inflammation which usually disappear within one week. To minimize this risk, blood collection will be performed by a trained and experienced phlebotomists. Written informed consent will be obtained from all subjects.

Condition or Disease Intervention/Treatment Phase
  • Dietary Supplement: Cowpea fortified with NaFeEDTA, in form of Toubani.
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
240 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Triple (Participant, Investigator, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Improving Iron Status Through Consumption Of Iron Fortified Cowpea: An Intervention Study
Study Start Date :
Sep 1, 2010
Actual Primary Completion Date :
Apr 1, 2011
Actual Study Completion Date :
Jul 1, 2011

Arms and Interventions

Arm Intervention/Treatment
No Intervention: Unfortified Toubani

Children in the school will receive, 3 times per week 66g of raw unfortified (no added Fe) cowpea in form of Toubani (a cowpea based snack).

Dietary Supplement: Cowpea fortified with NaFeEDTA, in form of Toubani.
66g raw Cowpea fortified with 10 mg Fe as NaFeEDTA, in form of Toubani, a cowpea snack. Ther snack will be given to the participants 3 times per week, for six month integrated in the school feeding trial.

Active Comparator: Fortified Cowpea

Study subjects will receive 3 times per week, as part of the school feeding programme 66g of raw fortified cowpea (with added 10mg Fe as NaFeEDTA)in form of Toubani (a cowpea based snack).

Dietary Supplement: Cowpea fortified with NaFeEDTA, in form of Toubani.
66g raw Cowpea fortified with 10 mg Fe as NaFeEDTA, in form of Toubani, a cowpea snack. Ther snack will be given to the participants 3 times per week, for six month integrated in the school feeding trial.

Outcome Measures

Primary Outcome Measures

  1. Iron deficiency anemia, defined by Hb<115 g/l; SF<12 microgram/l [Duration will be 6 months. Measurements will be performed at start and after 6 months of intervention.]

    Autcome parameters are Hemoglobin (Hb), Serum Ferritin (SF), Serum Transferrin Receptor (sTfR), and C - Reactive protein (CRP). Prevalence of iron deficiency anemia will be calculated based on the umber of subjects with Hb<115 g/l; SF<12 microgram/l.

Secondary Outcome Measures

  1. Serum Transferrin Receptor [6 months, measurements will be done at start and at the end of the intervention]

Eligibility Criteria

Criteria

Ages Eligible for Study:
6 Years to 12 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Children 6-12 years old

  • Regularly attending school, in grades 1-3

  • Apparently healthy, free of chronic illnesses and not taking chronic medication.

  • No medication nor supplemental iron at time of entry into the study

  • Informed consent obtained from at least one parent or guardian

Exclusion Criteria:
  • Children with severe anemia (Hb<70 g/l).

Contacts and Locations

Locations

Site City State Country Postal Code
1 Department of Community Nutrition, University for Development Studies Tamale Ghana

Sponsors and Collaborators

  • Wageningen University
  • Noguchi Memorial Institute for Medical Research
  • Nestlé Foundation

Investigators

  • Principal Investigator: Abdul R Abizari, Msc, Division of Human Nutrition, Wageningen University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Wageningen University
ClinicalTrials.gov Identifier:
NCT01208363
Other Study ID Numbers:
  • COWPEA
  • WUR10/13
First Posted:
Sep 23, 2010
Last Update Posted:
Sep 29, 2011
Last Verified:
Mar 1, 2011
Keywords provided by Wageningen University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Sep 29, 2011